Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

被引：6
|
作者：
Peters, Katherine B. [1 ]
Archer, Gerald E. [1 ]
Norberg, Pamela [1 ]
Xie, Weihua [1 ]
Threatt, Stevie [1 ]
Lipp, Eric S. [1 ]
Herndon, James Emmett [1 ]
Healy, Patrick [1 ]
Congdon, Kendra [1 ]
Sanchez-Perez, Luis [1 ]
Friedman, Henry S. [1 ]
Desjardins, Annick [1 ]
Vlahovic, Gordana [1 ]
Sampson, John H. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e13526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13526
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Single-agent bevacizumab for recurrent high-grade glioma.
    Greally, Megan
    Cadoo, Karen Anne
    Coleman, Niamh
    O'Brien, Michelle
    O'Riordan, Lynda M.
    Grogan, William
    Breathnach, Oscar S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Prognostic factors of salvage stereotactic radiotherapy for recurrent high-grade glioma.
    Takehana, K.
    Uto, M.
    Ogura, K.
    Arakawa, Y.
    Mineharu, Y.
    Mizowaki, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S673 - S674
  • [3] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Gerstner, Elizabeth Robins
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Pulverenti, Julee
    Vardam-Kaur, Trupti
    Stokes, Deirdre
    Smith, Katrina Howard
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Duda, Dan G.
    Jain, Rakesh K.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Dendritic cell vaccines for high-grade gliomas
    Eagles, Matthew E.
    Nassiri, Farshad
    Badhiwala, Jetan H.
    Suppiah, Suganth
    Almenawer, Saleh A.
    Zadeh, Gelareh
    Aldape, Kenneth D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1299 - 1313
  • [5] Symptom clusters in patients with high-grade glioma.
    Fox, Sherry
    Lyon, Debra
    Farace, Elana
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 213 - 213
  • [6] Alternative ways to improving the quality of life in combination treatment for high-grade glioma.
    Popov, Ivan A.
    Shikhlyarova, Alla I.
    Frantsiyants, Elena M.
    Rostorguev, Eduard E.
    Engibaryan, Marina A.
    Atmachidi, Dmitriy P.
    Kuznetsova, Natalya S.
    Kaplieva, Irina V.
    Bandovkina, Valeria A.
    Cheryarina, Natalia D.
    Pandova, Olga V.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    Current Treatment Options in Neurology, 2010, 12 : 321 - 333
  • [8] Recurrent High-Grade Glioma
    Quant, Eudocia C.
    Drappatz, Jan
    Wen, Patrick Y.
    Norden, Andrew D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (04) : 321 - 333
  • [9] Vaccines for glioblastoma and high-grade glioma
    Wheeler, Christopher J.
    Black, Keith L.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 875 - 886
  • [10] Effect of temozolomide chronotherapy in patients with high-grade glioma.
    Atluri, Himachandana
    Campian, Jian Li
    Talcott, Grayson
    Meyer, Melissa
    Slat, Emily
    Rubin, Joshua
    Huang, Jiayi
    Chheda, Milan G.
    Johanns, Tanner Michael
    Tao, Yu
    Govindan, Ashwin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345